Technical Analysis for ANTH - Anthera Pharmaceutic
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Down | Down | Down |
| Historical ANTH trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Doji - Bearish? | Reversal | -2.11% | |
| Wide Bands | Range Expansion | -2.11% | |
| Lower Bollinger Band Touch | Weakness | -2.11% | |
| Doji - Bearish? | Reversal | -2.45% | |
| Lower Bollinger Band Walk | Weakness | -2.45% | |
| Outside Day | Range Expansion | -2.45% | |
| Wide Bands | Range Expansion | -2.45% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Sector: Healthcare
- Industry: Biotechnology
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.
Biopharmaceutical California Autoimmune Diseases Enzyme Replacement Therapy Anthera Pharmaceuticals Immunoglobulin A Nephropathy
Biopharmaceutical California Autoimmune Diseases Enzyme Replacement Therapy Anthera Pharmaceuticals Immunoglobulin A Nephropathy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|
| Indicator | Value |
|---|---|
| 52 Week High | 0.1 |
| 52 Week Low | 0.0171 |
| Average Volume | 65,374 |
| 200-Day Moving Average | 0.0551 |
| 50-Day Moving Average | 0.0371 |
| 20-Day Moving Average | 0.0311 |
| 10-Day Moving Average | 0.0297 |
| Average True Range | 0.0085 |
| ADX | 56.3 |
| +DI | 5.6540 |
| -DI | 17.7215 |
| Chandelier Exit (Long, 3 ATRs ) | 0.0164 |
| Chandelier Exit (Short, 3 ATRs ) | 0.0440 |
| Upper Bollinger Band | 0.0366 |
| Lower Bollinger Band | 0.0256 |
| Percent B (%b) | 0.21 |
| BandWidth | 35.3698 |
| MACD Line | -0.0028 |
| MACD Signal Line | -0.0026 |
| MACD Histogram | -0.0001 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.0348 | ||||
| Resistance 3 (R3) | 0.0342 | 0.0314 | 0.0337 | ||
| Resistance 2 (R2) | 0.0314 | 0.0296 | 0.0317 | 0.0333 | |
| Resistance 1 (R1) | 0.0296 | 0.0285 | 0.0305 | 0.0302 | 0.0329 |
| Pivot Point | 0.0268 | 0.0268 | 0.0272 | 0.0271 | 0.0268 |
| Support 1 (S1) | 0.0250 | 0.0250 | 0.0259 | 0.0256 | 0.0229 |
| Support 2 (S2) | 0.0222 | 0.0239 | 0.0225 | 0.0225 | |
| Support 3 (S3) | 0.0204 | 0.0222 | 0.0222 | ||
| Support 4 (S4) | 0.0210 |
